share_log

Exploring MariMed's Earnings Expectations

Exploring MariMed's Earnings Expectations

探討MariMed的盈利預期
Benzinga ·  2024/11/06 05:02

MariMed (OTC:MRMD) is set to give its latest quarterly earnings report on Wednesday, 2024-11-06. Here's what investors need to know before the announcement.

MariMed(場外交易: MRMD)定於2024年11月6日(星期三)公佈最新的季度業績。投資者在公佈之前需要了解這些內容。

Analysts estimate that MariMed will report an earnings per share (EPS) of $-0.01.

分析師預計MariMed的每股收益(EPS)爲-0.01美元。

MariMed bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

MariMed的看多者希望聽到公司不僅超過這一預期,還提供積極的指導,或者對下一個季度的增長進行預測。

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

新投資者應該注意,有時不是盈利與否影響股票價格最大,而是其提供的指導或預測。

Past Earnings Performance

過去的盈利表現

In the previous earnings release, the company beat EPS by $0.01, leading to a 3.43% increase in the share price the following trading session.

在上一次業績公佈時,公司每股收益超出0.01美元,導致下一個交易日股價上漲3.43%。

Here's a look at MariMed's past performance and the resulting price change:

讓我們來看看MariMed過去的表現以及導致的股價變動:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.01 -0.01 0 0
EPS Actual 0 0 0.004 -0.01
Price Change % 3.0% -5.0% -2.0% -0.0%
季度 2024年第二季度 Q1 2024 2023年第四季度 2023年第三季度
每股收益預估值 -0.01 -0.01 0 0
每股收益實際值 0 0 0.004 -0.01
價格變更% 3.0% -5.0% -2.0% -0.0%
bigjpg

Performance of MariMed Shares

MariMed股票表現

Shares of MariMed were trading at $0.1629 as of November 04. Over the last 52-week period, shares are down 49.97%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

截至11月4日,MariMed股票交易價格爲0.1629美元。在過去的52週中,股價下跌了49.97%。鑑於這些回報通常爲負值,長期股東可能會看淡這次業績發佈。

To track all earnings releases for MariMed visit their earnings calendar on our site.

要跟蹤MariMed的所有業績發佈,請訪問我們網站上的業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文是由Benzinga的自動內容引擎生成,並由編輯審核。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論